Cognate Bioservices - the leader in cell therapy manufacturing services

Home

Accomplishments

Accomplishments

The combination of highly experienced staff and GMP facilities makes Cognate one of the most experienced contract manufacturers of cell-based products in the U.S. today. Cognate's staff has played a material role in the submission of 18 approved Investigational New Drug Applications (INDs) with the FDA for clinical trials of cell-based therapeutics in the U.S. These INDs cover numerous types of stem cells, immune cells, and other primary cell types.

Unparalleled Experience and Substantive Track Record:

	Cognate Memphis inspected by US FDA to Manufacture GMP Cell Therapy Products.

	Combined Managerial Experience Exceeds 200 Years in the Cell Therapy Field.

	Developed Manufacturing Processes for Cell-Based Products

	Experience With Manufacturing of Both Autologous and Allogeneic Products.

	Isolated and Expanded Human and Animal Cells

	Developed Innovative Closed Systems for Manufacturing of Adherent and Non-Adherent Cells.

	Successful Collaborations with Multiple Companies and Institutions That Have Resulted in Publications in Peer-Reviewed Journals and Presentations at Scientific Meetings.

	Conducted Manufacturing for Client Pivotal Clinical Trials.

To print this information, please click here.